---
figid: PMC5382109__nihms824859f6
figtitle: Therapeutic targets in B cell lymphoma of NFKB activation
organisms:
- NA
pmcid: PMC5382109
filename: nihms824859f6.jpg
figlink: /pmc/articles/PMC5382109/figure/F6/
number: F6
caption: 'Therapeutic targets in B cell lymphoma of NF-κB activation. The pathogenesis
  of B cell lymphoma activation involves constitutive activation of BCR, MyD88, and
  NF-κB pathway promoting cell survival through NF-κB signaling pathways. Small molecule
  inhibitor is designed to target specific signals in these complex networks to inhibit
  NF-κB in B cell lymphomas, including: (1), SYK (Fostamatinib/R406). (2), BTK (Ibrutinib;
  Acalabrutinib). (3), PKCb (Enzastaurin). (4), IKK (MLN120B). (5), HSP90 (KW-2478;
  SNX-7081). (6), proteasome (Bortezomib). (7), NEDD8-activating enzyme (MLN4924).
  (8), IRAK4 (RNAi). (9), Src-family kinase (Dasatinib).'
papertitle: NF-κB Signaling Pathway and its Potential as a Target for Therapy in Lymphoid
  Neoplasms.
reftext: Li Yu, et al. Blood Rev. ;31(2):77-92.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9621745
figid_alias: PMC5382109__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5382109__F6
ndex: 8a492e37-deda-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5382109__nihms824859f6.html
  '@type': Dataset
  description: 'Therapeutic targets in B cell lymphoma of NF-κB activation. The pathogenesis
    of B cell lymphoma activation involves constitutive activation of BCR, MyD88,
    and NF-κB pathway promoting cell survival through NF-κB signaling pathways. Small
    molecule inhibitor is designed to target specific signals in these complex networks
    to inhibit NF-κB in B cell lymphomas, including: (1), SYK (Fostamatinib/R406).
    (2), BTK (Ibrutinib; Acalabrutinib). (3), PKCb (Enzastaurin). (4), IKK (MLN120B).
    (5), HSP90 (KW-2478; SNX-7081). (6), proteasome (Bortezomib). (7), NEDD8-activating
    enzyme (MLN4924). (8), IRAK4 (RNAi). (9), Src-family kinase (Dasatinib).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MYD88
  - BCR
  - RN7SL263P
  - LYN
  - SYK
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - BTK
  - MALT1
  - PRKCB
  - TNFAIP3
  - IGKV1-27
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKBIA
  - IK
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - NFKB1
  - IL1R1
  - CD79B
  - Ibrutinib
---
